SCOTT MARTIN: Open Payments
NPI 1366762676 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 38 payments from 10 companies in 2025. Trend: 2023 $616 · 2024 $842 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Radius Health, Inc. | 7 | $199 |
| Amgen Inc. | 5 | $177 |
| Valinor Pharma, LLC | 14 | $160 |
| Stryker Corporation | 3 | $92 |
| Virtus Pharmaceuticals LLC | 2 | $50 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $48 |
| Dynasplint Systems Inc. | 1 | $46 |
| Forte Bio-Pharma LLC | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Tymlos, MOVANTIK, KRYSTEXXA, EVENITY, HYDROSET, LEVORPHANOL TARTRATE, JOURNAVX, Dynasplint.
Industry payments across LA — which companies pay providers there.
